VSGAX
Price
$100.94
Change
+$0.72 (+0.72%)
Updated
Jul 25 closing price
Net Assets
36.92B
WGICX
Price
$7.88
Change
+$0.07 (+0.90%)
Updated
Jul 25 closing price
Net Assets
596.58M
Interact to see
Advertisement

VSGAX vs WGICX

Header iconVSGAX vs WGICX Comparison
Open Charts VSGAX vs WGICXBanner chart's image
Vanguard Small Cap Growth Index Admiral
Price$100.94
Change+$0.72 (+0.72%)
VolumeN/A
Net Assets36.92B
Wasatch Micro Cap Institutional
Price$7.88
Change+$0.07 (+0.90%)
VolumeN/A
Net Assets596.58M
VSGAX vs WGICX Comparison Chart in %
Loading...
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSGAX has more cash in the bank: 36.9B vs. WGICX (597M). VSGAX pays higher dividends than WGICX: VSGAX (0.54) vs WGICX (0.00). VSGAX was incepted earlier than WGICX: VSGAX (14 years) vs WGICX (5 years). WGICX (1.59) is less costly to investors than VSGAX (0.07). WGICX is a more actively managed with annual turnover of: 51.00 vs. VSGAX (21.00). VSGAX has a lower initial minimum investment than WGICX: VSGAX (3000) vs WGICX (100000). VSGAX annual gain was more profitable for investors over the last year : 12.32 vs. WGICX (-0.88). VSGAX return over 5 years is better than : 40.33 vs. WGICX (-10.96).
VSGAXWGICXVSGAX / WGICX
Total Expense Ratio0.071.594%
Annual Report Gross Expense Ratio0.071.594%
Fund Existence14 years5 years-
Gain YTD2.611-4.831-54%
Front LoadN/AN/A-
Min. Initial Investment30001000003%
Min. Initial Investment IRAN/AN/A-
Net Assets36.9B597M6,181%
Annual Yield % from dividends0.540.00-
Returns for 1 year12.32-0.88-1,399%
Returns for 3 years38.3024.49156%
Returns for 5 years40.33-10.96-368%
Returns for 10 years121.74N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SITE131.25N/A
N/A
SiteOne Landscape Supply
PNFPP24.78-0.02
-0.08%
Pinnacle Financial Partners
GHI11.01-0.11
-0.99%
Greystone Housing Impact Investors LP
SOUN11.71-0.25
-2.09%
SoundHound AI
VRCA6.61-0.39
-5.57%
Verrica Pharmaceuticals Inc